Bacterial Infections  >>  atopaxar (E5555)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
atopaxar (E5555) / Eisai
NCT01587768: WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

Completed
N/A
1
US
Antibiotic prescription during the study period between January 1, 2004 and December 31, 2009
GlaxoSmithKline
Infections, Bacterial
07/14
07/14

Download Options